Search the GenomeWeb Intelligence Network Sponsored by : Illumina




Biotech Transfer Week
GenomeWeb News Premium Content
Existing subscribers login here.
Biotech Transfer Week is Now FREE - Everyone Can Subscribe!

Volume 2 - Number 34 | September 3, 2008

Subscriber Login
Subscribe to Biotech Transfer Week
Site Licenses
RSS Feed
Archives


In This Week's Issue

With $100K Genome in Reach, NHGRI Focuses Advanced-Sequencing Program on $1,000 Goal

Linz Researchers Say 454 Sequencing Will Improve Tissue Matching for Transplants

Julian Parkhill On Sequencing Pathogens ‘Broad and Deep’ At the Sanger Institute

Sequencing-Related US Patents Granted Aug. 6 – Sept. 2, 2008

Helicos BioSciences, Leerink Swann, Invitrogen, Applied Biosystems, University of California Los Angeles, Translational Genomics Institute, NIH, Scripps Translational Science Institute, RainDance Technologies, National Science Foundation, Brigham Young University, NHGRI, Navigenics, 23andMe, University of Cape Town, Johns Hopkins University, University of California at Berkeley, Joint Genome Institute, Myriad Genetics

SOLiD Whole Transcriptome Expression Kit

Stan Letovsky, Kary Mullis

Features
Departure of U of Delaware Scientist Could Spur Local Gene-Repair Spinout to Relocate
The departure of University of Delaware biology professor Erik Kmiec to West Virginia’s Marshall University may precipitate a similar flight from the state by Orphagenix, the gene-repair company he co-founded. Keeping the shop from staying is a dearth of gap funding to advance its technology to the clinical testing phase.

Proteostasis Therapeutics Secures $45M in VC Bets to Develop Protein Homeostasis Rxs
The company, which has licenses to intellectual property developed at Northwestern University, the Salk Institute for Biological Studies, and the Scripps Research Institute, is an example of how cooperation between tech-transfer offices at multiple academic institutions can result in a more attractive investment target, according to a company co-founder.

Tufts Spinout Quanterix Nets $15M in VC Cash for Single-Molecule Detection Tech
Tufts, which has an undisclosed equity stake in Quanterix, is betting that the upstart firm can follow in the footsteps of Illumina, whose 2000 IPO netted the university some $8 million, and whose BeadArray product sales continue to generate royalty payments for the school.

News Briefs
Burnham Institute for Medical Research, Cyntellect, Scripps Florida, Stem Cell Sciences, Edinburgh University, University Technologies International, University of Calgary, Materia, Olink, Uppsala University, AnaSpec, University of Washington, Azaya Therapeutics, University of Texas Health Science Center at San Antonio


People in the News
Beverly Lyman, Patrick Kelly, Marc Segal, Sam Fiorello



Copyright © 2008 GenomeWeb LLC. All rights reserved.

Publishing Systems Powered by iProduction [sam]